From: Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis
 | Sex | Race | Psychiatric disorder | Substance use disorder | Rural residence | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | N | Random effects | 95% CI | N | Random effects | 95% CI | N | Random effects | 95% CI | N | Random effects | 95% CI | N | Random effects | 95% CI |
Unadjusted OR | 22 | 1.33 | 1.17, 1.51 | 14 | 2.28 | 1.93, 2.70 | 11 | 3.94 | 3.09, 5.01 | 10 | 5.24 | 3.53, 7.76 | 5 | 0.93 | 0.72, 1.19 |
Outcome definition | |||||||||||||||
 Fatal overdose | 15 | 1.50 | 1.34, 1.68 | 11 | 2.65 | 2.26, 3.11 | 4 | 3.81 | 2.88, 5.05 | 4 | 7.05 | 5.15, 9.66 | 5 | 0.93 | 0.72,1.19 |
 Fatal and nonfatal overdose | 7 | 0.97 | 0.77, 1.21 | 3 | 0.99 | 0.53, 1.88 | 7 | 4.02 | 2.61, 6.21 | 6 | 4.08 | 1.78, 9.38 | - | - | - |
Study Design | |||||||||||||||
 Case control | 6 | 1.34 | 0.87, 2.06 | 6 | 2.81 | 2.04, 3.85 | 5 | 3.58 | 3.04, 4.20 | 5 | 5.65 | 4.10, 7.81 | 2 | 1.08 | 0.81, 1.43 |
 Cohort | 5 | 1.24 | 0.77, 2.01 | 2 | 1.72 | 0.64, 4.65 | 4 | 5.70 | 3.78, 8.59 | 3 | 8.34 | 4.32, 16.13 | - | - | - |
 Cross-sectional | 11 | 1.37 | 1.19, 1.59 | 6 | 2.07 | 1.61, 2.65 | 2 | 2.54 | 1.88, 3.43 | 2 | 2.12 | 1.43, 3.14 | 3 | 0.86 | 0.63, 1.18 |
Quality Assessment Score | |||||||||||||||
 High (7-10) | 10 | 1.27 | 0.89, 1.80 | 7 | 2.43 | 1.80, 3.27 | 9 | 4.29 | 3.32, 5.56 | 8 | 6.59 | 4.41, 9.85 | 2 | 0.95 | 0.60, 1.52 |
 Low (0-6) | 12 | 1.39 | 1.21, 1.60 | 7 | 2.14 | 1.68, 2.72 | 2 | 2.54 | 1.88, 3.43 | 2 | 2.12 | 1.43, 3.14 | 3 | 0.92 | 0.61, 1.37 |
Study Outcome | |||||||||||||||
 Medication overdose | 8 | 1.40 | 1.18, 1.65 | 4 | 2.33 | 1.68, 3.22 | 2 | 3.80 | 2.02, 7.12 | 2 | 4.84 | 1.42, 16.55 | 3 | 0.86 | 0.63, 1.18 |
 Prescription opioid overdose | 7 | 1.29 | 0.96, 1.74 | 4 | 2.50 | 2.06, 3.03 | 5 | 4.07 | 3.50, 4.72 | 4 | 6.21 | 4.60, 8.38 | 1 | 0.92 | 0.66, 1.27 |
 Overdose of any substance | 7 | 1.30 | 0.91, 1.86 | 6 | 1.98 | 1.37, 2.88 | 4 | 3.70 | 1.89, 7.24 | 4 | 4.86 | 1.57, 15.05 | 1 | 1.23 | 0.94, 1.59 |
Exclusions | |||||||||||||||
 Hulse et al. and Coben et al. | 20 | 1.36 | 1.19, 1.57 | - | - | - | - | - | - | - | - | - | - | - | - |
 Hulse et al., Coben et al., and Cerda et al. | 19 | 1.41 | 1.23, 1.62 | - | - | - | - | - | - | - | - | - | - | - | - |
 CDC 2009 Total Population | 21 | 1.32 | 1.16, 1.51 | - | - | - | - | - | - | - | - | - | - | - | - |
 CDC 2009 Medicaid only | 21 | 1.33 | 1.17, 1.52 | - | - | - | - | - | - | - | - | - | - | - | - |
 Havens and Silva | - | - | - | 12 | 2.54 | 2.17, 2.97 | - | - | - | - | - | - | - | - | - |
 Seal et al. | - | - | - | - | - | - | 10 | 3.79 | 2.95, 4.86 | - | - | - | - | - | - |
- | - | - | - | - | - | 8 | 3.55 | 2.39, 5.27 | - | - | - | - | - | - | |
 Bohnert et al. 2012 | - | - | - | - | - | - | - | - | - | 9 | 4.83 | 2.79, 8.36 | - | - | - |
 Havens | - | - | - | - | - | - | - | - | - | 9 | 5.92 | 3.99, 8.78 | - | - | - |
 CDC Non-illicit Drugs Utah 2005 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 0.85 | 0.68, 1.07 |
 Piercefield et al. 2010 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 1.01 | 0.77, 1.33 |